Prostate cancer treatment needs to get more personalized
(By Brian Helfand for STAT)
As a group, men who choose not to treat their early-stage prostate cancer aren’t any more likely1 to die from the disease within 10 years as men who choose treatment with surgery or radiation, which often come with potentially life-changing side effects. That’s the main finding of a landmark trial published recently2 in the New England Journal of Medicine. Continue reading article here……
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.